Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment
- 1 July 2003
- journal article
- Published by Elsevier in The Ocular Surface
- Vol. 1 (3) , 127-149
- https://doi.org/10.1016/s1542-0124(12)70140-4
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2003
- Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitisAnnals of Allergy, Asthma & Immunology, 2002
- Tear levels of interferon‐γ, interleukin (IL) ‐2, IL‐4 and IL‐5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitisClinical and Experimental Allergy, 2000
- Tumour necrosis factor alpha (TNFα) in tears of atopic patients after conjunctival allergen challengeClinical and Experimental Allergy, 1999
- Evaluation of Olopatadine, a New Ophthalmic Antiallergic Agent with Dual Activity, Using the Conjunctival Allergen Challenge ModelAnnals of Allergy, Asthma & Immunology, 1998
- Efficacy of Nedocromil Sodium and Cromolyn in an Experimental Model of Ocular AllergyAnnals of Allergy, Asthma & Immunology, 1996
- Eosinophil cationic protein in tears in allergic conjunctivitis.British Journal of Ophthalmology, 1996
- LevocabastineDrugs, 1991
- Mast cell numbers and staining characteristics in the normal and allergic human conjunctivaJournal of Allergy and Clinical Immunology, 1991
- Human conjunctival mast cells: Distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitisJournal of Allergy and Clinical Immunology, 1990